Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1976 1
1979 2
1980 1
1983 1
1984 2
1985 2
1986 3
1987 5
1988 1
1989 1
1990 2
1991 1
1992 4
1993 4
1994 6
1995 4
1996 9
1997 2
1998 2
1999 6
2000 6
2001 3
2002 1
2003 1
2004 4
2005 5
2006 3
2007 3
2008 4
2009 2
2010 7
2011 10
2012 6
2013 12
2014 13
2015 16
2016 12
2017 10
2018 11
2019 4
2020 8
2021 6
2022 8
2023 8
2024 7
2025 5
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Community health worker intervention to reduce worker exposure to volatile organic compounds in small business auto and beauty shops in a marginalized community: A cluster randomized controlled trial.
Gutenkunst SL, Lothrop N, Quijada C, Chaires M, Cortez I, Sandoval F, Balgos J, Gallardo EV, Gallardo PF, Sneed S, Honan JK, Bayless K, Chaidez X, Cuevas CR, Larson JL, Camargo FJ, Ramírez DM, Ingram M, Carvajal S, Billheimer D, Wolf AM, Beamer PI. Gutenkunst SL, et al. Among authors: larson jl. PLoS One. 2026 Apr 27;21(4):e0346356. doi: 10.1371/journal.pone.0346356. eCollection 2026. PLoS One. 2026. PMID: 42044132 Free PMC article. Clinical Trial.
Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.
Baden J, Lin CJ, Anfora AT, Beer J, Bisselou K, Bungo J, Corner AS, Danek T, Dickey J, Godsey JH, Johann DJ, Jones G, Karlin-Neumann G, Larson JL, Lee JSH, Liu L, Lopez Ramos D, Merriam D, Palomares M, Pena CE, Rathbun J, Rhodes K, Connolly Rohrbach JE, Saritas-Yildirim B, Sausen M, Zhang S, Leiman LC. Baden J, et al. Among authors: larson jl. JCO Precis Oncol. 2026 Jan;10:e2500267. doi: 10.1200/PO-25-00267. Epub 2026 Jan 14. JCO Precis Oncol. 2026. PMID: 41533993 Free PMC article.
220 results